Treatment outcomes of multidrug-resistant TB with selective use of new drugs.

Kwon, Y-S; Shin, J E; Kang, H; Jeon, D; Yim, J-J; Shim, T S

Kwon, Y-S; Shin, J E; Kang, H; Jeon, D; Yim, J-J; Shim, T S.

Afiliación

Kwon YS; Department of Internal Medicine, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, South Korea.
Shin JE; Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Kang H; Department of Chest Medicine, Masan National Tuberculosis Hospital, Masan, South Korea.
Jeon D; Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, South Korea.
Yim JJ; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Shim TS; Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.

Int J Tuberc Lung Dis ; 27(1): 55-60, 2023 01 01.

Article en En | MEDLINE | ID: mdl-36853130

Asunto(s)

Comités Consultivos; Tuberculosis Resistente a Múltiples Medicamentos; Humanos; Estudios de Cohortes; Resultado del Tratamiento; Fluoroquinolonas; Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Comités Consultivos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google